Try our Advanced Search for more refined results
Product Liability
-
February 17, 2026
Kids Cup Brand Says Testing Co. Missed High Lead Levels
A Massachusetts testing firm failed to identify higher-than-allowed lead levels in a line of stainless steel tumblers marketed for children, leading to a recall of about 400,000 cups, the brand's owner alleged in a state court complaint docketed Tuesday.
-
February 17, 2026
J&J Fights Beasley Allen's Bid To Pause Talc DQ Ruling
A New Jersey state court lacks standing to block an appellate panel's removal of Beasley Allen from representing hundreds of women with ovarian cancer pursuing claims against Johnson & Johnson over talcum powder, the pharmaceutical company has argued in an opposition brief.
-
February 17, 2026
Sick Juror Delays Meta Trial Ahead Of Zuckerberg Testimony
The first bellwether trial over thousands of claims that social media companies harm young people's mental health was delayed Tuesday due to a juror being hospitalized with an illness, although the California state judge in the case said the trial will resume one way or another on Wednesday, when Meta Platforms CEO Mark Zuckerberg is scheduled to testify.
-
February 17, 2026
Wisconsin Tribe Fights Enbridge's Line 5 Shutdown Delay
A Wisconsin tribe is fighting a request by Enbridge Energy Inc. to stay a June 16 deadline to shut down a portion of its Line 5 pipeline on reservation lands pending a Seventh Circuit decision, telling a federal district court that the Canadian company's motion is "jurisdictionally infirm."
-
February 17, 2026
Philips Settles Suit Over Sleep Machine Starting Home Fire
Medical equipment company Philips has reached a deal with a woman who alleged in North Carolina federal court that its sleep apnea breathing machine caught fire and caused burns to her mother's face and destroyed her home.
-
February 17, 2026
Bayer AG Unveils $7.3B Deal For Roundup Users
Bayer AG unit Monsanto has agreed to pay up to $7.25 billion over as many as 21 years to resolve current and future claims that exposure to the weed killer Roundup caused non‑Hodgkin lymphoma, under a proposed nationwide class settlement filed Tuesday in Missouri state court in St. Louis.
-
February 13, 2026
Stanford Prof Tells Jury Studies Confirm Social Media Addiction
A Stanford University professor of psychiatry and addiction returned to the witness stand Friday in a California bellwether trial over claims that social media companies harm young people's mental health, saying studies have concluded that addiction to platforms such as YouTube and Instagram is real and can hurt mental health.
-
February 13, 2026
7th Circ. Forces Mercedes 3G Obsolescence Suit Into Arb.
Mercedes-Benz drivers who sued the automaker after its subscription-based roadside assistance and other features became obsolete will have to take their claims to arbitration, the Seventh Circuit ruled on Friday, saying the customers agreed to deal with disputes outside court.
-
February 13, 2026
Atty Fee Fight Brewing After Google's Chatbot Injury Settlement
An Orlando, Florida, law firm has urged a federal court to grant it contingency fees from a pending settlement in a suit accusing Google LLC and a chatbot company of causing the suicide of a teen, saying the firm was left in the dark about the deal.
-
February 13, 2026
Cheap Costco Chicken Made At Tainted Plant, Suit Says
Costco on Thursday was hit with a proposed class action alleging that its highly popular rotisserie chickens — one of the wholesaler's staple loss leaders — are processed at a plant systematically tainted with salmonella.
-
February 13, 2026
7th Circ. Wary To Infer American Airlines Uniforms Were Toxic
A Seventh Circuit panel on Friday appeared skeptical of American Airlines workers' argument that it had provided sufficient evidence to infer toxic employee uniforms caused their skin rashes and other symptoms, with one judge suggesting such a broad reading of Illinois law and federal tort doctrine would allow plaintiffs to say "to heck with the experts."
-
February 13, 2026
FDA Removes Boxed Warnings From HRT Products
Six menopause hormone therapies will no longer have warnings on their label about heart disease, breast cancer and dementia, after the U.S. Food and Drug Administration said it removed them so that women can make decisions "free from exaggeration or fear."
-
February 13, 2026
J&J Hit With $250K Verdict In 2nd Philly Talc Trial
A Philadelphia jury hit Johnson & Johnson with a $250,000 verdict on Friday, finding the company liable in the case of a woman whose family claimed that using the company's once-famous talcum powder contributed to her fatal ovarian cancer.
-
February 13, 2026
Creek Nation's Ala. Burial Site Claims Face Dismissal Bids
An Alabama tribe, the Interior Department and Auburn University are asking a federal district court to dismiss an ongoing challenge by the Muscogee (Creek) Nation over a sacred burial site, arguing a lack of standing and sovereign immunity.
-
February 13, 2026
CareDx Seeks High Court Review Of $45M False Ad Case
Transplant diagnostics company CareDx has asked the U.S. Supreme Court to review a Third Circuit decision that erased a nearly $45 million jury award against rival Natera in a false advertising case, arguing the appeals court is the only one that forbids juries from inferring consumer deception when determining damages.
-
February 13, 2026
Prenatal Testing Co. Missed Fatal Condition, Couple Say
A Massachusetts couple say Natera Inc. misreported the results of tests for a genetic marker linked to a fatal kidney condition, leading to the conception of a child who died an hour after birth.
-
February 13, 2026
UK Litigation Roundup: Here's What You Missed In London
This past week in London has seen a former U.S. defense contractor convicted of tax evasion face legal action, French football club Olympique Lyonnais sued following a $97 million ruling against its owner John Textor, consulting giant Kroll targeted by a South African airline, and H&M hit with a claim alleging it copied protected sunglasses designs. Here, Law360 looks at these and other new claims in the U.K.
-
February 12, 2026
Uber $8.5M Bellwether Verdict Boosts Plaintiffs' MDL Leverage
Uber was recently hit with an $8.5 million verdict in the first bellwether trial in multidistrict litigation over driver sex assaults, and one particular finding by the jury bodes well for the thousands of cases remaining in the MDL, experts tell Law360, and could prove pivotal for any future global settlement.
-
February 12, 2026
Challenge To 3D-Printed Gun Law Fails, 3rd Circ. Rules
The First Amendment does not protect the distribution of "purely functional code" that would allow for the 3D printing of guns, the Third Circuit ruled Thursday, ending a challenge to a New Jersey law from a Texas-based firearm company and a gun rights group.
-
February 12, 2026
Split 4th Circ. Denies Stay Lift In CertainTeed Unit's Ch. 11
A split panel of the Fourth Circuit on Wednesday upheld lower court rulings that left in place a stay of asbestos injury litigation facing the bankrupt affiliate of building material maker CertainTeed, with the majority ruling the debtor filed its case in good faith.
-
February 12, 2026
DC Circ. Is Asked To Vet New DOT Immigrant Truck Driver Rule
Drivers and labor unions on Thursday petitioned the D.C. Circuit to review the U.S. Department of Transportation's new final rule tightening states' screening procedures and eligibility criteria for nondomiciled commercial driver's licenses issued to immigrants.
-
February 12, 2026
Vape Co. Seeks Stay Of $1.6M Judgment In Battery Blast Suit
A vape wholesaler is asking the North Carolina Supreme Court to stay a $1.6 million judgment it was ordered to pay to the estate of a man who suffered burns when a lithium ion battery exploded in his pocket, while the estate on Thursday filed an opposition to the stay.
-
February 12, 2026
'Texit' Crypto Offering Halted By Texas Securities Regulator
Texas' state securities regulator has filed an emergency cease-and-desist order against an enterprise selling mining interests for a cryptocurrency invoking the Texas secession movement, alleging the scheme constitutes a fraudulent and unregistered offering and sale of securities.
-
February 12, 2026
Town Officials Off Hook For Railroad's Axed Superfund Deal
A Massachusetts intermediate appellate panel affirmed that two Hopedale officials are immune from claims that they torpedoed a railroad's contract to ship uranium-contaminated soil through their town of 6,000, saying the officials "had every right" to ask questions.
-
February 11, 2026
Avon Loses Appeal Over $51M Verdict In Mesothelioma Case
A California appellate court on Wednesday refused to wipe out a $51 million jury verdict against Avon for the cancer a woman says she got from using its asbestos-tainted talc, rejecting the cosmetic company's qualms with expert testimony and the trial court's evidentiary rulings.
Expert Analysis
-
Ill. Toxic Tort Jurisdiction Law Raises Constitutional Concerns
Illinois' S.B. 328, purporting to broaden state courts' jurisdictional reach over out-of-state corporations, is presented as a measure aimed at facilitating recovery in toxic tort cases, but the legislation raises significant due process and dormant commerce clause issues, say attorneys at Alston & Bird.
-
Rebuttal
BigLaw Settlements Should Not Spur Ethics Deregulation
A recent Law360 op-ed argued that loosening law firm funding restrictions would make BigLaw firms less inclined to settle with the Trump administration, but deregulating legal financing ethics may well prove to be not merely ineffective, but counterproductive, says Laurel Kilgour at the American Economic Liberties Project.
-
5 Ways Lawyers Can Earn Back The Public's Trust
Amid salacious headlines about lawyers behaving badly and recent polls showing the public’s increasingly unfavorable view of attorneys, we must make meaningful changes to our culture to rebuild trust in the legal system, says Carl Taylor at Carl Taylor Law.
-
How To Successfully Challenge Jurors For Cause In 5 Steps
To effectively challenge a potential juror for cause, attorneys should follow a multistep framework rather than skipping straight to the final qualification question, says Ken Broda-Bahm at Persuasion Strategies.
-
Opinion
Furtive Changes To Federal Health Data Threaten Admissibility
A recent study showing that nearly 100 U.S. federal health datasets have been modified this year without any notation in official change logs should concern plaintiffs counsel, defense counsel and judges alike — because undermining data's integrity, authenticity and chain of custody threatens its admissibility in litigation, say attorneys at Kershaw Talley.
-
Class Actions At The Circuit Courts: August Lessons
In this month's review of class action appeals, Mitchell Engel at Shook Hardy discusses key takeaways from federal appellate decisions involving topics including antitrust, immigration, consumer fraud, birthright citizenship under the Fourteenth Amendment, and product defects.
-
Series
Hiking Makes Me A Better Lawyer
On the trail, I have thought often about the parallels between hiking and high-stakes patent litigation, and why strategizing, preparation, perseverance and joy are important skills for success in both endeavors, says Barbara Fiacco at Foley Hoag.
-
Opinion
Time For Full Disclosure Of Third-Party Funding In MDLs
It is appropriate that the Federal Advisory Committee on Civil Rules is considering a rule to require disclosure of third-party litigation funding in civil litigation — something that is particularly needed in multidistrict litigation, which now comprises more than half of all civil cases in the federal courts, says Eric Hudson at Butler Snow.
-
Series
Law School's Missed Lessons: Negotiation Skills
I took one negotiation course in law school, but most of the techniques I rely on today I learned in practice, where I've discovered that the process is less about tricks or tactics, and more about clarity, preparation and communication, says Grant Schrantz at Haug Barron.
-
AG Watch: Texas Embraces The MAHA Movement
Attorneys at Kelley Drye examine Texas Attorney General Ken Paxton's actions related to the federal Make America Healthy Again movement, and how these actions hinge on representations or omissions by the target companies as opposed to specific analyses of the potential health risks.
-
Opinion
Bar Exam Reform Must Expand Beyond A Single Updated Test
Recently released information about the National Conference of Bar Examiners’ new NextGen Uniform Bar Exam highlights why a single test is not ideal for measuring newly licensed lawyers’ competency, demonstrating the need for collaborative development, implementation and reform processes, says Gregory Bordelon at Suffolk University.
-
A Simple Way Courts Can Help Attys Avoid AI Hallucinations
As attorneys increasingly rely on generative artificial intelligence for legal research, courts should consider expanding online quality control programs to flag potential hallucinations — permitting counsel to correct mistakes and sparing judges the burden of imposing sanctions, say attorneys at Lankler Siffert & Wohl and Connors.
-
DOJ Consumer Branch's End Leaves FDA Litigation Questions
With the dissolution of the U.S. Department of Justice's Consumer Protection Branch set to occur by Sept. 30, companies must carefully monitor how responsibility is reallocated for civil and criminal enforcement cases related to products regulated by the U.S. Food and Drug Administration, say attorneys at Foley & Lardner.
-
Asbestos Trusts And Tort Litigation Are Still Not Aligned
A recent ruling by a New York state court in James Petro v. Aerco International highlights the inefficiencies that still exist in asbestos litigation — especially regarding the continued lack of coordination between the asbestos tort system and the well-funded asbestos trust compensation system, says Peter Kelso at Roux.
-
Opinion
Closing The Chemical Safety Board Is A Mistake
The U.S. Chemical Safety and Hazard Investigation Board, which investigates the root causes of major chemical incidents, provides an essential component of worker and community safety and should not be defunded, says Reuben Guttman at Guttman Buschner.